Periodic acid Schiff reaction in childhood lymphoblastic leukaemia. The Medical Research Council Working Party on Childhood Leukaemia.

Periodic acid Schiff reaction in childhood lymphoblastic leukaemia. The Medical Research Council Working Party on Childhood Leukaemia.

AIMS: To assess the prevalence and degree of periodic acid Schiff (PAS) positivity in blast cells from children with lymphoblastic leukaemia (ALL); its association with other disease characteristics; and its clinical importance in predicting the outcome of treatment. METHODS: Marrow slides from entr...

Descripció completa

Dades bibliogràfiques
Autors principals:	Lilleyman, J, Britton, J, Anderson, L, Richards, S, Bailey, C, Chessells, J
Format:	Journal article
Idioma:	English
Publicat:	1994

Ítems similars

Acute lymphoblastic leukaemia in infancy: experience in MRC UKALL trials. Report from the Medical Research Council Working Party on Childhood Leukaemia.
per: Chessells, J, et al.
Publicat: (1994)

Continuing (maintenance) therapy in lymphoblastic leukaemia: lessons from MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
per: Chessells, J, et al.
Publicat: (1997)

Cytomorphology of childhood lymphoblastic leukaemia: a prospective study of 2000 patients. United Kingdom Medical Research Council's Working Party on Childhood Leukaemia.
per: Lilleyman, J, et al.
Publicat: (1992)

Testicular irradiation in childhood lymphoblastic leukaemia. Medical Research Council Working Party on Leukemia in Childhoods.
per: Eden, O, et al.
Publicat: (1990)

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.
per: Eden, O, et al.
Publicat: (2000)

Prognostic importance of myelosuppression during maintenance treatment of lymphoblastic leukaemia. Leukaemia in Childhood Working Party of the Medical Research Council.
per: Dolan, G, et al.
Publicat: (1989)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience. Medical Research Council Working Party on Childhood Leukaemia.
per: Wheeler, K, et al.
Publicat: (1998)

Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia.
per: Chessells, J, et al.
Publicat: (1995)

Medical Research Council leukaemia trial--UKALL V: an attempt to reduce the immunosuppressive effects of therapy in childhood acute lymphoblastic leukemia. Report to the Council by the Working Party on Leukaemia in Childhood.
per: Chessells, J, et al.
Publicat: (1986)

Cytogenetics and prognosis in childhood lymphoblastic leukaemia: results of MRC UKALL X. Medical Research Council Working Party in Childhood Leukaemia.
per: Chessels, J, et al.
Publicat: (1997)

Results of Medical Research Council Childhood Leukaemia Trial UKALL VIII (report to the Medical Research Council on behalf of the Working Party on Leukaemia in Childhood).
per: Eden, O, et al.
Publicat: (1991)

Long survival in childhood lymphoblastic leukaemia.
per: Chessells, J, et al.
Publicat: (1987)

Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials.
per: Chessells, J, et al.
Publicat: (1995)

Clearance of marrow infiltration after 1 week of therapy for childhood lymphoblastic leukaemia: clinical importance and the effect of daunorubicin. The Medical Research Council's Working Party on Childhood Leukaemia.
per: Lilleyman, J, et al.
Publicat: (1997)

Blast cell vacuoles in childhood lymphoblastic leukaemia.
per: Lilleyman, J, et al.
Publicat: (1988)

Late relapsing childhood lymphoblastic leukaemia.
per: Frost, L, et al.
Publicat: (1997)

Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997
per: Eden, O, et al.
Publicat: (2000)

Late relapsing childhood acute lymphoblastic leukaemia.
per: Frost, L, et al.
Publicat: (1998)

Secondary acute myeloid leukaemia in children treated for acute lymphoblastic leukaemia.
per: Eden, O, et al.
Publicat: (1998)

Progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI).
per: Hargrave, DR, et al.
Publicat: (2001)

Comparison of bone marrow transplant and chemotherapy treatment for relapsed childhood acute lymphoblastic leukaemia (ALL.)
per: Wheeler, K, et al.
Publicat: (1996)

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.
per: Chessells, J, et al.
Publicat: (2002)

Improved survival with early intensification: combined results from the Medical Research Council childhood ALL randomised trials, UKALL X and UKALL XI. Medical Research Council Working Party on Childhood Leukaemia.
per: Richards, S, et al.
Publicat: (1998)

Intraocular relapse of childhood acute lymphoblastic leukaemia.
per: Somervaille, T, et al.
Publicat: (2003)

Benefit of intensified treatment for all children with acute lymphoblastic leukaemia: results from MRC UKALL XI and MRC ALL97 randomised trials. UK Medical Research Council's Working Party on Childhood Leukaemia.
per: Hann, I, et al.
Publicat: (2000)

Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X.
per: Chessells, J, et al.
Publicat: (1992)

Analysis of the immunophenotype of children treated on the Medical Research Council United Kingdom Acute Lymphoblastic Leukaemia Trial XI (MRC UKALLXI). Medical Research Council Childhood Leukaemia Working Party.
per: Hann, I, et al.
Publicat: (1998)

Comparison of bone marrow transplant and chemotherapy for relapsed childhood acute lymphoblastic leukaemia: the MRC UKALL X experience
per: Wheeler, K, et al.
Publicat: (1998)

Benefit of dexamethasone compared with prednisolone for childhood acute lymphoblastic leukaemia: results of the UK Medical Research Council ALL97 randomized trial.
per: Mitchell, C, et al.
Publicat: (2005)

Thioguanine compared with mercaptopurine in childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council randomised trial ALL97.
per: Lennard, L, et al.
Publicat: (2005)

French American British (FAB) morphological classification of childhood lymphoblastic leukaemia and its clinical importance.
per: Lilleyman, J, et al.
Publicat: (1986)

Acute myeloid leukaemia in childhood: the costs and benefits of intensive treatment.
per: Phillips, M, et al.
Publicat: (1991)

A second course of treatment for childhood acute lymphoblastic leukaemia: long-term follow-up is needed to assess results.
per: Chessells, J, et al.
Publicat: (1994)

Comparison of bone marrow transplantation with chemotherapy for high risk childhood acute lymphoblastic leukaemia in first remission.
per: Wheeler, K, et al.
Publicat: (1998)

Comparison of allogeneic transplant versus chemotherapy for relapsed childhood acute lymphoblastic leukaemia in the MRC UKALL R1 trial. MRC Childhood Leukaemia Working Party.
per: Harrison, G, et al.
Publicat: (2000)

Results of Medical Research Council trial UKALL IX in acute lymphoblastic leukaemia in adults: report from the Medical Research Council Working Party on Adult Leukaemia.
per: Durrant, I, et al.
Publicat: (1993)

Toxicity and efficacy of 6-thioguanine versus 6-mercaptopurine in childhood lymphoblastic leukaemia: a randomised trial.
per: Vora, A, et al.
Publicat: (2006)

Intensive chemotherapy and bone marrow transplantation for infant lymphoblastic leukaemia.
per: Chessells, J, et al.
Publicat: (1997)

Remission death in acute lymphoblastic leukaemia: a changing pattern.
per: Atra, A, et al.
Publicat: (1993)

Benefit of targeted intensification for NCI high risk childhood lymphoblastic leukaemia: Results of the United Kingdom medical research council trial ALL97 and ALL97/99.
per: Vora, A, et al.
Publicat: (2006)